经眼睑电刺激治疗视网膜色素变性:N-of-1单盲随机对照试验系列的研究方案
视网膜色素变性是一种遗传性疾病,目前缺乏可逆转或延缓进展的干预措施。本研究采用N-of-1单盲随机交叉对照设计,计划严格纳入12名参与者,每周期干预8周,评估经眼睑电刺激对视野、最佳矫正视力、视网膜电图、视觉功能问卷及视网膜结构的影响,以评价其安全性和有效性。
要点
- 视网膜色素变性为遗传性疾病,目前缺乏可逆转或延缓进展的干预措施。
- 经眼睑电刺激在动物研究和小型临床研究中显示可能减缓疾病进展。
- 本研究为首项前瞻性随机研究,采用N-of-1单盲交叉设计评估经眼睑电刺激。
核心结论
- 该试验将评估微电流刺激治疗视网膜色素变性的有效性和安全性,并通过N-of-1试验为临床应用提供高质量证据。
研究设计与样本
- 随机前瞻性研究,采用N-of-1试验进行3次单盲交叉比较。
- 每个比较的干预期分为治疗期和对照期,随机安排。
- 研究者将严格按照纳入和排除标准招募12名参与者。
主要发现
- 每个8周干预周期后检查的主要结局指标为视野评估。
- 其他关注的变量包括最佳矫正视力、视网膜电图评估的视网膜功能以及NEI VFQ-25问卷评估的视觉功能。
- 将使用光学相干断层扫描和眼底自发荧光对视网膜变化进行客观评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Retinitis pigmentosa (RP) is an inherited disease characterized by a progressive loss of rod photoreceptors of the eye, leading to irreversible blindness. To date, to our knowledge, no clinical prospective studies have been undertaken that could document the effect of interventions that could reverse or reduce the progression of this disease. The application of microcurrent stimulation (ES) of the eye in the treatment of chronic eye diseases such as glaucoma and age-related macular degeneration has been used over several decades and has been reported to have beneficial effects to reduce the progression of these blinding diseases and has been supported by animal studies and smaller clinical studies, but to date, no large randomized clinical trials on the use of microcurrent therapy have been published. More recent clinical reports have also shown beneficial effects of ES on slowing the progression of RP but also lacks data from robust prospective clinical outcome studies. To our knowledge, this is the first prospective randomized study to evaluate the safety and clinical effectiveness of transpalpebral electrical stimulation (TpES) on the progression of RP. METHODS: Randomized prospective study using N-of-1 trial 3 single-blind, crossover comparisons. The intervention period of each comparison is divided into treatment period and control period which are randomized arranged. Twelve participants will be strictly recruited in N-of-1 trial by the researcher in accordance with the inclusion and exclusion criteria. The main outcome of interest examined after each cycle of the 8-week intervention period is the assessment of the visual field (VF). Other variables of interest are best corrected visual acuity (BCVA), retinal function using electroretinogram (ERG), and visual function using NEI VFQ-25 questionnaire. Objective assessments of retinal changes will be undertaken using optical coherence tomography (OCT) and fundus autofluorescence (FAF). DISCUSSION: The trial will evaluate the efficacy and safety of microcurrent stimulation on RP and provide high-quality evidence for clinical application through N-of-1 trial. TRIAL REGISTRATION: Chinese Clinical Trial Registry; ChiCTR2300067357; https://www.chictr.org.cn/showproj.html?proj=174635 . Registered on 5 January 2023.
引用
- Zhou W, Huang Z, Xu K, et al. Transpalpebral electrical stimulation for the treatment of retinitis pigmentosa: study protocol for a series of N-of-1 single-blind, randomized controlled trial. Trials. 2024. PMID: 38279157. doi:10.1186/s13063-024-07933-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。